Hi thanks. I actually meant funding for 3CL. It seems to me with a few EUAs on our way to full approval in the US at some point, and thus giving more validity to Tollovid making doctors comfortable prescribing it, perhaps 3CL wouldn't need such a big raise, or in a perfect world, any
on a side note, I don't agree with GC that most people with LC are afraid of the govt and FDA - I know people trying to get into clinics and have recommended T. to them, but they are worried about interactions and want to talk to their doctors, who of course have never heard of it
Market Data 
Markets 
AI
